{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:49:02Z","timestamp":1765889342046,"version":"3.41.2"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, is a highly contagious respiratory disease with widespread societal impact. The symptoms range from cough, fever, and pneumonia to complications affecting various organs, including the heart, kidneys, and nervous system. Despite various ongoing efforts, no effective drug has been developed to stop the spread of the virus. Although various types of medications used to treat bacterial and viral diseases have previously been employed to treat COVID-19 patients, their side effects have also been observed. The way SARS-CoV-2 infects the human body is very specific, as its spike protein plays an important role. The S subunit of virus spike protein cleaved by human proteases, such as furin protein, is an initial and important step for its internalization into a human host. Keeping this context, we attempted to inhibit the furin using phytochemicals that could produce minimal side effects. For this, we screened 408 natural phytochemicals from various plants having antiviral properties, against furin protein, and molecular docking and dynamics simulations were performed. Based on the binding score, the top three compounds (robustaflavone, withanolide, and amentoflavone) were selected for further validation. MM\/GBSA energy calculations revealed that withanolide has the lowest binding energy of \u221257.2 kcal\/mol followed by robustaflavone and amentoflavone with a binding energy of \u221245.2 kcal\/mol and \u221239.68 kcal\/mol, respectively. Additionally, ADME analysis showed drug-like properties for these three lead compounds. Hence, these natural compounds robustaflavone, withanolide, and amentoflavone, may have therapeutic potential for the management of SARS-CoV-2 by targeting furin.<\/jats:p>","DOI":"10.3389\/fcimb.2024.1391288","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T12:54:03Z","timestamp":1718196843000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Structure-based virtual screening methods for the identification of novel phytochemical inhibitors targeting furin protease for the management of COVID-19"],"prefix":"10.3389","volume":"14","author":[{"given":"Prashant","family":"Kumar Tiwari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandeep","family":"Chouhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richa","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anis Ahmad","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Al-Zharani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf","family":"Ahmed Qurtam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahd A.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niraj Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumud","family":"Pant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/nu13051550","article-title":"Emergent drug and nutrition interactions in COVID-19: A comprehensive narrative review","volume":"13","author":"A\u011fag\u00fcnd\u00fcz","year":"2021","journal-title":"Nutrients"},{"key":"B2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1145\/1188455.1188544","article-title":"Molecular dynamics\u2014Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1815584","article-title":"Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease","volume":"127","author":"C","year":"2020","journal-title":"J. Biomol Struct. Dyn"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1089\/cmb.2019.0323","article-title":"Analysis of the physicochemical properties of acaricides based on lipinski\u2019s rule of five","volume":"27","author":"Chen","year":"2020","journal-title":"J. Comput. Biol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108254","article-title":"Furin inhibitors block SARS-coV-2 spike protein cleavage to suppress virus production and cytopathic effects","volume":"33","author":"Cheng","year":"2020","journal-title":"Cell Rep."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/iub.2793","article-title":"Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease","volume":"76","author":"Choudhary","year":"2023","journal-title":"IUBMB Life"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104742","article-title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","volume":"176","author":"Coutard","year":"2020","journal-title":"Antiviral Res."},{"key":"B8","unstructured":""},{"key":"B9","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s11224-022-02056-1","article-title":"Consensus docking and MM-PBSA computations identify putative furin protease inhibitors for developing potential therapeutics against COVID-19","volume":"33","author":"Dankwa","year":"2022","journal-title":"Struct. Chem."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.14125433.v1","article-title":"Repurposing multi-targeting plant natural product scaffolds in silico against SARS-coV-2 non-structural proteins implicated in viral pathogenesi","author":"de Leon","year":"2021"},{"key":"B11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s43440-021-00344-x","article-title":"A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2","volume":"74","author":"Devi","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.chembiol.2022.02.001","article-title":"A highly selective, cell-permeable furin inhibitor BOS-318 rescues key features of cystic fibrosis airway disease","volume":"29","author":"Douglas","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00128-22","article-title":"Distinctive roles of furin and TMPRSS2 in SARS-CoV-2 infectivity","volume":"96","author":"Essalmani","year":"2022","journal-title":"J. Virol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/jcb.30214","article-title":"Identification of polypharmacological anticancerous molecules against Aurora kinase family of proteins","volume":"123","author":"Gupta","year":"2022","journal-title":"J. Cell. Biochem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: A force field providing broad coverage of drug-like small molecules\u00a0and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jtcme.2022.02.001","article-title":"Natural products as a source of novel drugs for treating SARS-CoV2 infection","volume":"12","author":"Isidoro","year":"2022","journal-title":"J. Traditional Complementary Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00894-015-2789-8","article-title":"Comparative molecular field analysis and molecular dynamics studies of \u03b1\/\u03b2 hydrolase domain containing 6 (ABHD6) inhibitors","volume":"21","author":"Kaczor","year":"2015","journal-title":"J. Mol. Model."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9101373","article-title":"Extracellular vesicle-based therapy for COVID-19: promises, challenges and future prospects","volume":"9","author":"Karn","year":"2021","journal-title":"Biomedicines"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1080\/07391102.2021.2025429","article-title":"N-acetylglucosamine-phosphatidylinositol de-N-acetylase as a novel target for probing potential inhibitor against Leishmania donovani","volume":"41","author":"Kumar","year":"2023","journal-title":"J. Biomolecular Structure Dynamics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/ph15091045","article-title":"Plant metabolites as SARS-coV-2 inhibitors candidates: in silico and in vitro studies","volume":"15","author":"Lopes","year":"2022","journal-title":"Pharmaceuticals"},{"key":"B24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.virol.2021.01.015","article-title":"Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion","volume":"556","author":"Mondal","year":"2021","journal-title":"Virology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"27852791","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e05990","article-title":"Can EChinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019","volume":"7","author":"Nagoor Meeran","year":"2021","journal-title":"Heliyon"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21752","article-title":"CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections","volume":"82","author":"Nagoor Meeran","year":"2020","journal-title":"Drug Dev. Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/9735626","article-title":"Theta-defensins to counter COVID-19 as furin inhibitors: in silico efficiency prediction and novel compound design","volume":"2022","author":"Negahdaripour","year":"2022","journal-title":"Comput. Math. Methods Med."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.5656773","article-title":"Ayurveda may play a preventive role against viral infections including SARS-CoV-2 by the inactivation of furin protease","volume":"97","author":"Paul","year":"2020","journal-title":"J. Indian Chem. Soc."},{"key":"B31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s00894\u2013022-05391\u20136","article-title":"In silico evaluation of flavonoids as potential inhibitors of SARS-CoV-2 main nonstructural proteins (Nsps)\u2014amentoflavone as a multitarget candidate","volume":"28","author":"Portilla-Mart\u00ednez","year":"2022","journal-title":"J. Mol. Model."},{"key":"B32","doi-asserted-by":"publisher","first-page":"10096","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J. Chem. Phys."},{"key":"B33","unstructured":""},{"key":"B34","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ijmmb.2022.02.005","article-title":"Basic virology of SARS-coV 2","volume":"40","author":"Ravi","year":"2022","journal-title":"Indian J. Med. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2022.198845","article-title":"Insight towards the effect of the multi basic cleavage site of SARS-CoV-2 spike protein on cellular proteases","volume":"318","author":"Shokeen","year":"2022","journal-title":"Virus Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s12088-023-01121-5","article-title":"Plant-derived natural compounds as an emerging antiviral in combating COVID-19","volume":"63","author":"Singh","year":"2023","journal-title":"Indian J. Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.14715\/cmb\/2021.67.4.17","article-title":"Tripeptides from Allium subhirsitum L. extracts: Pharmacokinetics properties, toxicity prediction and in silico study against SARS-CoV-2 enzymes and pro-inflammatory proteins","volume":"67","author":"Snoussi","year":"2021","journal-title":"Cell Mol. Biol. (Noisy-le-grand)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2174\/2666796701999200826114306","article-title":"Virtual screening of potential therapeutic inhibitors against spike, helicase, and polymerase of SARS-cov-2 (COVID-19)","volume":"2","author":"Tazeen","year":"2021","journal-title":"Coronaviruses"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105512","article-title":"Multifaceted roles of plant derived small molecule inhibitors on replication cycle of SARS-CoV-2","volume":"168","author":"Uma Reddy","year":"2022","journal-title":"Microbial Pathogenesis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.32381\/JPSR","article-title":"In-Silico Studies for the Inhibition of Proprotein Convertase Furin using Synthetic Compound Databases to see the Effectiveness against SARS-CoV-2 Transmission","volume":"38","author":"Uppal","year":"2022","journal-title":"J. Plant Sci. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jtcme.2021.04.001","article-title":"Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells","volume":"12","author":"Vardhan","year":"2022","journal-title":"J. Traditional Complementary Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.antiviral.2015.01.011","article-title":"Protease inhibitors targeting coronavirus and filovirus entry","volume":"116","author":"Zhou","year":"2015","journal-title":"Antiviral Res."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1391288\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T12:54:08Z","timestamp":1718196848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1391288\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":44,"alternative-id":["10.3389\/fcimb.2024.1391288"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1391288","relation":{},"ISSN":["2235-2988"],"issn-type":[{"type":"electronic","value":"2235-2988"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"article-number":"1391288"}}